GentiBio closed a $157m series A venture capital round, while clinical trial innovator Reify Health raised a $220m series C and Neurelis secured $150m. Also, IPOs slowed in August, but Adagio and Eliem grossed $309.4m and $80m, respectively, and RNA firm Greenlight will go public in a $282m SPAC deal. 

Biotronik is touting successful clinical trial results with its Orsiro sirolimus-eluting coronary stent while continuing to develop a resorbable stent.

In this new roundup feature focusing on the most notable developments in digital health, we pick the key news to date.

Happify Health raises $73m to expand digital mental health platform; Viz.ai secures $71m to extend software beyond stroke care coordination.